Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001564590-15-010422
Filing Date
2015-11-12
Accepted
2015-11-12 06:05:11
Documents
10
Period of Report
2015-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q nk-10q_20150930.htm 10-Q 2140936
2 EX-31.1 nk-ex311_8.htm EX-31.1 16629
3 EX-31.2 nk-ex312_7.htm EX-31.2 16904
4 EX-32.1 nk-ex321_6.htm EX-32.1 14110
  Complete submission text file 0001564590-15-010422.txt   7491305

Data Files

Seq Description Document Type Size
5 XBRL INSTANCE DOCUMENT nk-20150930.xml EX-101.INS 1274054
6 XBRL TAXONOMY EXTENSION SCHEMA nk-20150930.xsd EX-101.SCH 59229
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE nk-20150930_cal.xml EX-101.CAL 45125
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE nk-20150930_def.xml EX-101.DEF 319418
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE nk-20150930_lab.xml EX-101.LAB 470811
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE nk-20150930_pre.xml EX-101.PRE 413198
Mailing Address 3530 JOHN HOPKINS COURT SAN DIEGO CA 92121
Business Address 3530 JOHN HOPKINS COURT SAN DIEGO CA 92121 (858) 633-0300
NantKwest, Inc. (Filer) CIK: 0001326110 (see all company filings)

EIN.: 431979754 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-37507 | Film No.: 151221056
SIC: 2836 Biological Products, (No Diagnostic Substances)